Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$10.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cross Country Healthcare, Inc. Issues Q4, FY 2010 Guidance Below Analysts' Estimates
Cross Country Healthcare, Inc. announced that for the fourth quarter of 2010, it expects revenue to be in the range of $113-$116 million and earnings per diluted share to be in the range of $0.01-$0.03. For fiscal 2010, the Company expects revenue to be in the $468-$471 million range and earnings per diluted share to be in the range of $0.11-$0.13. According to Reuters Estimates, analysts were expecting the Company to report EPS of $0.05 on revenues of $122 million for the fourth quarter of 2010 and EPS of $0.16 on revenues of $480 million for fiscal 2010.
Latest Developments for Cross Country Healthcare Inc
- Cross Country Healthcare, Inc. Issues Q2 2012 Guidance; EPS Guidance Below Analysts' Estimates
- Cross Country Healthcare, Inc. Issues Q1 2012 Guidance below Analysts' Estimates
- Cross Country Healthcare, Inc. Issues Q4 2011 Revenue And EPS Guidance Below Analysts' Estimates; Comments Q4 2011 EBITDA Guidance
- Cross Country Healthcare, Inc. Issues Q3 2011 Guidance In Line With Analysts' Estimates; Comments On Q3 2011 EBITDA Guidance
Latest Key Developments in Healthcare Facilities / Services
- Share this
- Link this
- Digg this
Follow Reuters